To confirm the role of DARPP-32 in EGFR TKI resistance using a different NSCLC xenograft model, gefitinib-sensitive PC9P cells stably overexpressing DARPP-32 were subcutaneously injected into the flank of SCID mice. Here, EGFR is linked to non-small cell lung carcinoma.